Abstract

Maturity-onset diabetes of the young (MODY) is a clinically heterogeneous group of disorders characterized by nonketotic diabetes mellitus, an autosomal dominant mode of inheritance, an onset usually before the age of 25 years and frequently in childhood or adolescence, and a primary defect in the function of the beta cells of the pancreas. MODY can result from mutations in any one of at least six different genes (Table 1). One of these genes encodes the glycolytic enzyme glucokinase (associated with MODY 2),3 and the other five encode transcription factors: hepatocyte nuclear factor (HNF) 4α (associated with MODY 1),4 HNF-1α (MODY . . .

Keywords

Maturity onset diabetes of the youngGlucokinaseMedicineHepatocyte nuclear factorsDiabetes mellitusHNF1AInternal medicinePathophysiologyEndocrinologyGeneGeneticsTranscription factorBiologyType 2 diabetes

Affiliated Institutions

Related Publications

Publication Info

Year
2001
Type
review
Volume
345
Issue
13
Pages
971-980
Citations
1131
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

1131
OpenAlex

Cite This

Stefan S. Fajans, Graeme I. Bell, Kenneth S. Polonsky (2001). Molecular Mechanisms and Clinical Pathophysiology of Maturity-Onset Diabetes of the Young. New England Journal of Medicine , 345 (13) , 971-980. https://doi.org/10.1056/nejmra002168

Identifiers

DOI
10.1056/nejmra002168